UTAH MEDICAL PRODUCTS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $11.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $11.80M, a 11.33% decline from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $13.31M, a 19.12% increase from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $11.17M, a 10.46% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $12.47M, a 3.92% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|
| 2025-12-31 | $11.80M 10-K · filed 2026-03-27 | |
| 2024-12-31 | $13.31M 10-K · filed 2025-03-26 | $13.31M 10-K · filed 2026-03-27 |
| 2023-12-31 | $11.17M 10-K · filed 2025-03-26 | $11.17M 10-K · filed 2026-03-27 |
| 2022-12-31 | $12.47M 10-K · filed 2025-03-26 | |
| 2021-12-31 | $12.00M 10-K · filed 2024-03-26 | |
| 2020-12-31 | $9.03M 10-K/A · filed 2023-03-28 | |
| 2019-12-31 | $11.55M 10-K · filed 2022-03-25 | |
| 2018-12-31 | $10.13M 10-K · filed 2021-03-26 | |
| 2017-12-31 | $9.12M 10-K · filed 2020-03-16 | |
| 2016-12-31 | $8.69M 10-K · filed 2019-03-14 | |
| 2015-12-31 | $7.97M 10-K · filed 2018-03-06 | |
| 2014-12-31 | $7.72M 10-K · filed 2017-03-08 | |
| 2013-12-31 | $7.59M 10-K · filed 2016-03-10 | |
| 2012-12-31 | $7.99M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $7.79M 10-K · filed 2014-03-12 | |
| 2010-12-31 | $8.57M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |